Christensen Thorkil K. 4
4 · BIOMIMETIC THERAPEUTICS, INC. · Filed Mar 6, 2013
Insider Transaction Report
Form 4
Christensen Thorkil K.
Director
Transactions
- Disposition to Issuer
Common Stock
2013-03-01−2,507→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to the Agreement and plan of Merger ("Merger Agreement") dated as of November 19, 2012, by and among the company, Wright Medical Group, Inc. ("Wright"), Achilles Merger Subsidiary, Inc. and Achilles Acquisition Subsidiary, LLC in exchange for the following merger consideration per share of the Company's common stock: (a) $1,50 in cash, without interest; (b) 0.2482 of a share of Wright's common stock; and (c) one contingent value right ("CVR") issued by Wright.